Skip to main content
. 2021 Jun 18;11:684531. doi: 10.3389/fonc.2021.684531

Figure 5.

Figure 5

Serum HCP5 in monitoring tumor dynamics in GC patients. (A) Detection of serum HCP5 expression in GC pre-operation patients (n=98), post-operation patients (n=46) and recurrence patients (n=57). (B) Altered expression of serum HCP5 in 15 paired samples preoperatively and postoperatively. (C) The survival curve of patients with GC. *P < 0.05, **P < 0.01, ****P < 0.001, NS means no statistically difference.